When used as per recommended dosage, the systemic availability of diclofenac from DICLOTROY is very low as compared to oral formulation of diclofenac. Hence the risk of drug interactions with other oral medicinal products is reduced. Concurrent acetylsalicylic acid or other NSAIDs may result in an increased incidence of adverse reaction.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
